E-LIB Suche - Ergebnisse für: Kluger, Aaron Y.

1

Trends in Hospital Admissions for Systolic and Diastolic He..:

Afzal, Aasim ; van Zyl, Johanna ; Nisar, Tariq...
The American Journal of Cardiology. 171 (2022) - p. 99-104 , 2022

2

Usefulness of Statins as Secondary Prevention Against Recur..:

Tecson, Kristen M. ; Kluger, Aaron Y. ; Cassidy-Bushrow, Andrea E....
The American Journal of Cardiology. 176 (2022) - p. 37-42 , 2022

Link: https://doi.org/10.1016/..

3

Class Effects of SGLT2 Inhibitors on Cardiorenal Outcomes:

, In: Textbook of Cardiorenal Medicine,

Kluger, Aaron Y. - p. 279-294 , 2020

Link: https://doi.org/10.1007/..

4

Implications of Chronic Kidney Disease on the Epidemiology ..:

, In: Textbook of Cardiorenal Medicine,

McCullough, Peter A. ; Kluger, Aaron Y. - p. 1-5 , 2020

Link: https://doi.org/10.1007/..

5

The Effects of SGLT2 Inhibitors on Cardiovascular and Renal..:

Lo, Kevin Bryan ; Gul, Fahad ; Ram, Pradhum...
Cardiorenal Medicine. 10 (2019) 1 - p. 1-10 , 2019

Link: https://doi.org/10.1159/..

6

Class effects of SGLT2 inhibitors on cardiorenal outcomes:

Kluger, Aaron Y. ; Tecson, Kristen M. ; Lee, Andy Y....
Cardiovascular Diabetology. 18 (2019) 1 - p. , 2019

Link: https://doi.org/10.1186/..

7

Trends in post–heart transplant biopsies for graft rejectio..:

Jamil, Aayla K ; Afzal, Aasim ; Nisar, Tariq...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059886/. , 2021

Link: http://www.ncbi.nlm.nih...

8

Continuation of Chronic Heart Failure Therapies During Hear..:

Singhania, Girish ; Ejaz, Abutaleb A ; McCullough, Peter A...
https://doi.org/10.31083/j.rcm.2019.03.562. , 2019

Link: https://repository.tcu.e..

9

Class effects of SGLT2 inhibitors on cardiorenal outcomes:

Aaron Y. Kluger ; Kristen M. Tecson ; Andy Y. Lee...
http://link.springer.com/article/10.1186/s12933-019-0903-4. , 2019

Link: https://doi.org/10.1186/..

10

Left ventricular myocardial strain and tissue characterizat..:

Higgins, Angela Y. ; Arbune, Amit ; Soufer, Aaron...
PLOS ONE. 16 (2021) 2 - p. e0246764 , 2021

Link: https://doi.org/10.1371/..

11

Time from starting Immune Checkpoint Inhibitor (ICI) to cli..:

Angela Y. Higgins (10170400) ; Amit Arbune (10170403) ; Aaron Soufer (6170573)...
https://figshare.com/articles/figure/Time_from_starting_Immune_Checkpoint_Inhibitor_ICI_to_clinical_presentation_/14066182. , 2021

Link: https://doi.org/10.1371/..

12

Cardiac magnetic resonance imaging functional analysis:

Angela Y. Higgins (10170400) ; Amit Arbune (10170403) ; Aaron Soufer (6170573)...
https://figshare.com/articles/journal_contribution/Cardiac_magnetic_resonance_imaging_functional_analysis_/14066167. , 2021

Link: https://doi.org/10.1371/..

13

Sample quantitative late gadolinium enhancement:

Angela Y. Higgins (10170400) ; Amit Arbune (10170403) ; Aaron Soufer (6170573)...
https://figshare.com/articles/figure/Sample_quantitative_late_gadolinium_enhancement_/14066176. , 2021

Link: https://doi.org/10.1371/..

14

Varying CMR presentations of Immune Checkpoint Inhibitor (I..:

Angela Y. Higgins (10170400) ; Amit Arbune (10170403) ; Aaron Soufer (6170573)...
https://figshare.com/articles/figure/Varying_CMR_presentations_of_Immune_Checkpoint_Inhibitor_ICI_associated_cardiotoxicity_/14066188. , 2021

Link: https://doi.org/10.1371/..

15

Sample CMR strain analysis:

Angela Y. Higgins (10170400) ; Amit Arbune (10170403) ; Aaron Soufer (6170573)...
https://figshare.com/articles/figure/Sample_CMR_strain_analysis_/14066173. , 2021

Link: https://doi.org/10.1371/..